Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Apollomics Inc.
Headquarters: Foster City, CA, United States of America
Website: https://www.apollomicsinc.com/...
Year Founded: 2016
Status: Public
Industry Sector: Finance
CEO: Guo-Liang Yu, PhD
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: -11.28
Exchange/Ticker 1: NASDAQ:APLM
Exchange/Ticker 2: N/A
Latest Market Cap: $6,836,600
BioCentury | Mar 5, 2024
Management Tracks
Promotions at Ally Bridge
Plus: Schreyer named CTO at Anagenex, and updates from 4M, Sitryx and Apollomics
BioCentury | Jan 12, 2024
Management Tracks
BayHelix names Goodwin’s Pan chair, gives BioCentury’s Flores achievement award
Plus: new CEO at Junshi and an update from SimBioSys
BioCentury | Nov 16, 2023
Deals
Nov. 16 Quick Takes: Q32 takes merger route to NASDAQ via Homology deal
Plus: SpringWorks’ neurofibromatosis program headed for NDA and updates from Astellas, Propella, BMS, Merck, Nature’s Toolbox, Apollomics and Avistone
BioCentury | Oct 20, 2023
Deals
Asia’s rise in innovation: a China Healthcare Summit preview
BayHelix’s Yu and McKinsey’s Zhou join the BioCentury team to preview the Nov. 2-3 conference in Shanghai
BioCentury | Sep 25, 2023
Product Development
Cross-border deals, innovation and AI: a podcast preview of the East-West Summit
BayHelix’s Yu and McKinsey’s Leclerc join the BioCentury team to preview the upcoming East-West Summit
BioCentury | Mar 31, 2023
Deals
March 30 Quick Takes: Scynexis deal gives GSK another anti-infective
Plus: AstraZeneca in-licenses CLDN18.2 asset from China’s KYM, updates from newly public biotechs Apollomics and GI Innovation and more
BioCentury | Oct 28, 2022
Deals
Going global: is globalization a necessity for biotech success?
McKinsey’s Le Deu and BayHelix’s Yu join BioCentury’s editors to preview the upcoming East-West Summit
BioCentury | Sep 15, 2022
Finance
Sept. 14 Quick Takes: Apollomics going public via SPAC deal
Plus RayzeBio raises $160M in series D for radiopharmaceuticals, and updates from Point, Larimar, Worg and more
BioCentury | Jul 27, 2022
Management Tracks
Two River, Merck alum Snyder joins Generate as CMO
Plus Nagorse becomes CMO at Affini-T and updates from Apollomics, Circle and more
BioCentury | Apr 5, 2022
Management Tracks
Sharpless to leave NCI
Plus Legend hires Zymeworks alum Fang to lead research, early development and updates from Freenome, Urovant, Tessa, eGenesis
Items per page:
1 - 10 of 33